Monday, December 13, 2021 5:05:33 PM
https://www.globenewswire.com/news-release/2021/12/13/2350962/0/en/Allogene-Therapeutics-Reports-Positive-Phase-1-Data-from-the-ALPHA-Trials-in-Non-Hodgkin-s-Lymphoma-at-the-63rd-Annual-Meeting-of-the-American-Society-of-Hematology.html
Recent ALLO News
- Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) • GlobeNewswire Inc. • 07/01/2024 12:30:00 PM
- Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:33:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:35:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:34:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:25:40 PM
- Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:40:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 08:38:13 PM
- Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock • GlobeNewswire Inc. • 05/13/2024 08:47:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:03:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:02:19 PM
- Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- Allogene Therapeutics Announces Q2 Investor Conference Participation • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update • GlobeNewswire Inc. • 03/05/2024 01:30:00 PM
- Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:30:30 PM
- Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia • GlobeNewswire Inc. • 02/16/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 10:45:39 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM